Losartan Overdose and Accidental Extra Dose: What Women Need to Know

Import from "@/components/mdx"

What Is Losartan and How Does It Work?

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for hypertension, type 2 diabetic nephropathy, and stroke risk reduction in patients with left ventricular hypertrophy. It works by blocking the AT1 receptor, the main receptor through which angiotensin II tightens blood vessels, raises blood pressure, and triggers aldosterone release. When that receptor is blocked, your arteries relax, your kidneys excrete more sodium, and blood pressure falls.

The Active Metabolite Women Should Know About

Losartan itself is a prodrug. Your liver converts about 14% of an oral dose into a far more potent metabolite called E-3174, which is roughly 10 to 40 times more active than the parent compound at the AT1 receptor. This conversion depends on the CYP2C9 enzyme. Women metabolize CYP2C9 substrates at rates comparable to men on average, but CYP2C9 poor metabolizers generate less E-3174, meaning less blood-pressure lowering effect and potentially less risk of hypotension from a given dose, while ultra-rapid metabolizers may see exaggerated effects.

What the LIFE Trial Showed

The Losartan Intervention For Endpoint reduction in hypertension (LIFE) trial enrolled 9,193 patients with hypertension and left ventricular hypertrophy, randomizing them to losartan 50 mg (titrated to 100 mg) or atenolol. Over a mean of 4.8 years, losartan reduced the composite primary endpoint of cardiovascular death, stroke, and myocardial infarction by 13% relative to atenolol, driven largely by a 25% reduction in stroke risk. Roughly 47% of LIFE participants were women, which is better representation than many older CV trials.

How Losartan Is Dosed Across Different Life Stages in Women

Getting the dose right matters more than most patients realize, and that target shifts across your life.

Reproductive Years (Ages 18 to 45)

The standard starting dose for hypertension is 25 mg to 50 mg once daily, titrated up to 100 mg if needed. Women of reproductive age prescribed losartan must use reliable, highly effective contraception throughout treatment because losartan is teratogenic. This is non-negotiable and covered in full in the pregnancy section below.

Perimenopause (Roughly Ages 45 to 55)

Blood pressure tends to rise as estrogen declines in perimenopause. Systolic blood pressure increases by an average of 5 to 6 mmHg in the menopause transition, and this happens independently of aging. If your clinician is increasing your losartan dose during this period, be aware that vasomotor symptoms (hot flashes, flushing) can mimic or worsen orthostatic hypotension, making falls a real concern. Dose increases should ideally happen in small increments, and you should monitor your blood pressure at home.

Post-Menopause

Post-menopausal women prescribed losartan at higher doses (100 mg daily) face a greater chance of symptomatic hypotension, particularly in the first hour after each dose. Blood pressure circadian patterns shift after menopause, with more women losing the normal nocturnal blood pressure dip. If your doctor prescribes losartan once daily, taking it in the morning rather than at night may reduce the risk of a nighttime blood pressure crash, though your individual pattern should guide timing.

PCOS

Hypertension in women with PCOS is common. The prevalence of hypertension in women with PCOS may be as high as 40%, particularly those with obesity and insulin resistance. ARBs like losartan are generally preferred over ACE inhibitors in women of reproductive age with PCOS who also have proteinuria, because the side-effect profile is similar but ARBs are slightly better tolerated. The teratogenic warning, however, applies identically to both drug classes.

What Happens If You Take Too Much Losartan?

Taking more losartan than prescribed most commonly results in a steep drop in blood pressure. The severity depends on how much extra you took, your baseline blood pressure, your hydration status, and whether you are taking other blood-pressure medications.

The Most Common Symptoms

The primary overdose effect is hypotension. You may feel:

• Dizziness or light-headedness, especially when you stand
• Sudden weakness or feeling faint
• A rapid or pounding heartbeat (compensatory tachycardia), though bradycardia has also been reported
• Headache
• Nausea

These symptoms typically appear within one to two hours of ingestion, reflecting when peak plasma concentrations of losartan and E-3174 occur.

Less Common but Serious Effects

In large overdoses or in women who are already volume-depleted (from vomiting, diarrhea, heavy menstrual bleeding, or diuretic use), the blood pressure drop can be severe enough to cause organ hypoperfusion. Reports of bradycardia and electrolyte disturbances including hyperkalemia have appeared in overdose cases. Hyperkalemia, an elevated potassium level, is a particular concern if you also take potassium-sparing diuretics, potassium supplements, or have underlying kidney disease.

Why Women May Be More Vulnerable to Hypotension

Women have, on average, lower body mass and lower plasma volume than men at equivalent doses. Some pharmacokinetic studies show higher peak losartan concentrations in women at the same mg/kg dose, meaning the blood-pressure effect per tablet may be stronger. This sex difference is not always addressed in prescribing, and it means that an accidental double dose carries a meaningfully higher hypotension risk for a smaller woman than for a larger man taking the same regimen.

What to Do If You Took an Extra Dose

Do not assume you can wait and see. Symptoms may not appear immediately, especially if you just ate a large meal (food slows absorption).

Immediate Steps

1. Sit or lie down. If you feel dizzy, get to a safe position to prevent a fall injury.
2. Call Poison Control. In the US, dial 1-800-222-1222. They are available 24 hours a day and can advise whether you need emergency care based on exactly how much you took and your clinical situation.
3. Do not induce vomiting unless Poison Control or a clinician explicitly tells you to.
4. If you are unconscious, having a seizure, or cannot be roused, call 911 immediately.

What Emergency Clinicians Will Do

There is no antidote for losartan overdose. Treatment is supportive:

• IV fluids to restore blood pressure if you are hypotensive
• Vasopressors such as norepinephrine or dopamine in severe refractory hypotension
• Cardiac monitoring for at least four to six hours
• Electrolyte monitoring, especially potassium and creatinine
• Activated charcoal may be considered if you present within one to two hours of ingestion and your airway is protected, though evidence for meaningful benefit in ARB overdose specifically is limited

Losartan is not significantly removed by hemodialysis, so dialysis is not a treatment strategy.

If You Simply Missed a Dose and Are Tempted to Double Up

Skipping a single dose of losartan will cause your blood pressure to rise temporarily, but it will not cause a hypertensive crisis in most people. Take the missed dose as soon as you remember, unless your next dose is within about six hours, in which case skip the missed one and resume your regular schedule. Never take two doses at once to make up for a missed one.

Pregnancy and Lactation: The Non-Negotiable Warning

Losartan is absolutely contraindicated throughout all three trimesters of pregnancy. This warning is stronger and more specific than what patients often hear, so it is worth stating precisely.

Why the Risk Is Severe

Angiotensin II plays a key role in fetal kidney development. Blocking AT1 receptors during the second and third trimesters causes fetal renal tubular dysplasia, oligohydramnios (too little amniotic fluid), neonatal renal failure, skull hypoplasia, limb contractures, and fetal or neonatal death. These effects are not theoretical. They have been documented in human case reports.

First-trimester exposure is also not considered safe. Although the most catastrophic fetal organ effects occur in the second and third trimesters, early embryo implantation and placental development also depend partly on the renin-angiotensin system, and miscarriage risk with ARB exposure in the first trimester is a documented concern.

The FDA removed the old pregnancy category system in 2015, but the practical guidance is clear: losartan is a known human teratogen when used in the second and third trimesters. ACOG supports this position, noting that ACE inhibitors and ARBs should be discontinued as soon as pregnancy is detected.

What You Should Do If You Are Taking Losartan and Become Pregnant

Stop losartan immediately and contact your prescribing clinician the same day. Your blood pressure will need to be managed with a pregnancy-safe antihypertensive such as labetalol, nifedipine, or methyldopa. Do not simply stop all blood pressure treatment; uncontrolled hypertension in pregnancy carries its own serious risks, including preeclampsia and placental abruption.

Contraception Requirement

If you are taking losartan and are of reproductive age, you need reliable contraception. This means a method with a typical-use failure rate well below 5%, such as an IUD (hormonal or copper), a subdermal implant, or consistent oral contraceptive use combined with a backup method. A 2020 ACOG committee opinion on pharmacologic therapy for hypertension specifically calls out the need for pre-pregnancy counseling and contraception planning for women prescribed ARBs or ACE inhibitors.

If you are planning to become pregnant, talk to your prescriber at least three months in advance to transition to a pregnancy-compatible antihypertensive.

Breastfeeding and Lactation

There are no adequate human data on losartan transfer into breast milk. Animal studies show it does transfer. Because of the potential for serious effects on a nursing infant's kidney function and blood pressure, The Drugs and Lactation Database (LactMed) advises against losartan use during breastfeeding and recommends considering an alternative antihypertensive with more established safety data, such as nifedipine or labetalol.

Who Is Losartan Right For, and Who Should Avoid It

Good Candidates by Life Stage and Condition

• Post-menopausal women with hypertension and left ventricular hypertrophy. The LIFE trial showed particular stroke reduction in this population.
• Women with type 2 diabetes and proteinuria. The RENAAL trial found that losartan 100 mg daily reduced the risk of the primary renal composite endpoint by 16% in patients with type 2 diabetes and nephropathy.
• Women with PCOS and hypertension or proteinuria who are using reliable contraception.
• Women who cannot tolerate ACE inhibitors due to cough. ARBs do not cause the bradykinin-mediated cough that ACE inhibitors do, making losartan a preferred switch.

Women Who Should Not Take Losartan

• Pregnant women at any stage. Full stop.
• Women with bilateral renal artery stenosis. Blocking angiotensin II in this setting can cause acute kidney injury.
• Women with severe hepatic impairment. Losartan is metabolized by the liver; a standard dose may behave like an overdose in cirrhosis.
• Women taking aliskiren (a direct renin inhibitor) who also have diabetes or GFR <60 mL/min. This combination is contraindicated due to excess risk of hypotension, hyperkalemia, and renal impairment.
• Women allergic to losartan or any ARB.

Sex-Specific Drug Interactions to Watch

Women are prescribed more concurrent medications on average than men at equivalent ages, and several interactions are particularly relevant.

NSAIDs (ibuprofen, naproxen, including drugs commonly used for menstrual pain) blunt the blood pressure-lowering effect of losartan and increase the risk of acute kidney injury. This matters most during heavy menstrual periods or endometriosis flares when NSAID use spikes.

Hormonal contraceptives. Combined oral contraceptives containing estrogen can raise blood pressure and partially counteract losartan. If your blood pressure is well-controlled on losartan and you start a combined hormonal contraceptive, your blood pressure should be re-checked within four to six weeks.

Spironolactone or eplerenone. Both are sometimes prescribed in women for PCOS-related hyperandrogenism, acne, or fluid retention. Combining them with losartan raises the risk of hyperkalemia significantly. Potassium levels need monitoring within two to four weeks of combining these drugs.

Potassium supplements. Even over-the-counter potassium supplements can push potassium into a dangerous range when combined with losartan. Your prescriber should know about every supplement you take.

Monitoring Your Losartan Therapy: A Practical Checklist for Women

Ongoing monitoring reduces both under-treatment (blood pressure too high) and accidental toxicity (blood pressure too low).

What to Check and When

| Test | Timing | Why It Matters for Women | |---|---|---| | Blood pressure at home | Weekly for 4 weeks after any dose change, then monthly | Catches hypotensive episodes, especially perimenopausal women | | Serum potassium and creatinine | 2 to 4 weeks after starting or dose change; then every 6 to 12 months | ARBs raise potassium; kidney function affects clearance | | Pregnancy test | Before starting; if any missed period | Losartan is a known human teratogen | | Urine albumin-to-creatinine ratio | Annually if prescribed for diabetic nephropathy | Tracks treatment response in PCOS-related or diabetic kidney disease | | Liver function tests | If any signs of hepatic disease | Hepatic impairment increases drug accumulation |

The Evidence Gap: What We Still Do Not Know About Losartan in Women

Women have historically been under-represented in large cardiovascular trials, and losartan is no exception. The LIFE trial enrolled roughly 47% women, which is better than many predecessor studies, but sex-stratified pharmacokinetic data for losartan specifically remain limited in the published literature. Most overdose management guidelines are derived from case reports and general ARB toxicology data rather than from controlled trials. The recommendation to use IV fluids and vasopressors is based on physiologic reasoning and clinical experience, not on randomized evidence in overdose populations.

"The renin-angiotensin system is not a male system," notes one framing from reproductive endocrinology literature, reflecting the growing recognition that estrogen modulates angiotensin-converting enzyme activity and AT1 receptor density across the menstrual cycle. Estrogen down-regulates AT1 receptor expression in vascular smooth muscle, which may explain why pre-menopausal women have a degree of natural protection against the vasoconstrictor effects of angiotensin II, and why that protection dissolves after menopause, often requiring antihypertensive medication for the first time. This physiology is directly relevant to how strongly losartan will lower blood pressure in you depending on your hormonal status, yet no standard dosing guideline currently accounts for menopausal status when recommending starting doses.

This is an honest evidence gap, and your clinician should know it exists.

Losartan and Female-Specific Conditions: A Summary

Hypertension in Perimenopause and Menopause

The 2023 American Heart Association statement on hypertension in women explicitly recognizes that blood pressure management strategies must account for menopausal status. Losartan is a reasonable choice in post-menopausal women, particularly those with concurrent LVH or diabetes, but starting at 25 mg and titrating slowly reduces hypotension risk during the transition period.

Diabetic Nephropathy and PCOS-Related Kidney Disease

The RENAAL trial demonstrated that losartan 100 mg daily reduced the composite of doubling of serum creatinine, end-stage renal disease, or death by 16% in patients with type 2 diabetes and nephropathy. Women with PCOS who develop insulin resistance and early proteinuria may benefit from this same nephroprotective effect, though direct trial data in PCOS-specific populations are lacking.

Hormonal Acne and Androgenic Alopecia

Losartan does not treat these conditions directly. Some women with PCOS are prescribed both losartan (for blood pressure or proteinuria) and spironolactone (for androgenic symptoms). As noted above, the potassium risk in this combination requires active monitoring.

Endometriosis and NSAID Use

Women with endometriosis often use high-dose NSAIDs for pain during flares. Each NSAID course can blunt losartan's effectiveness and stress the kidneys. If you have endometriosis and are on losartan, your prescriber should know about your NSAID use, and you should check your blood pressure during flares to catch any rise in blood pressure.

Quick-Reference: Losartan Overdose Response by Symptom Severity

| Situation | What to Do | |---|---| | Took one extra dose, no symptoms | Call Poison Control (1-800-222-1222); monitor BP at home for 4 to 6 hours | | Dizziness, light-headedness | Lie down, drink water (if no fluid restriction), call Poison Control | | Fainting or inability to stand | Call 911; do not drive yourself | | Chest pain or irregular heartbeat | Call 911 immediately | | Pregnant and took any losartan dose | Call your OB or MFM the same day; switch to a safe antihypertensive | | Unknown amount taken | Go to the emergency department; bring your pill bottle |